-
Payer Survey Uncovers Likely Increased Management Strategies Following Release of Initial 10 Drugs Selected for Price Negotiation
Mar 10, 2025, 14:00 PM -
Provider perspectives on the DREAMM-7 Trial Results and Belantamab Mafodotin (belamaf) in Combination with Bortezomib and Dexamethasone (B-Vd) as a Potential Treatment for Patients with Relapsed or Refractory Multiple Myeloma (R/R MM)
Mar 10, 2025, 14:00 PM -
Data Extraction from Full-Text PDFs Using Large Language Models for Systematic Reviews
Mar 10, 2025, 14:00 PM -
Impact of an Outpatient Rifaximin Access Program on 30-Day Readmission Rates in Hepatic Encephalopathy Patients Initiated on Rifaximin in the Inpatient Setting
Mar 10, 2025, 14:00 PM -
Qualitative Insights on Meaningful Change in Symptoms and Impacts for Patients With Alpha-1 Antitrypsin Deficiency
Mar 10, 2025, 14:00 PM -
Analysis of the Epidemiological Burden of Osteoarthritis in Hungary Based on Data From the Global Burden of Disease Study
Mar 10, 2025, 14:00 PM -
Assessing the Relationship Between Pruritus and Work Productivity Among Individuals With PBC and Pruritus: Results From the ITCH-E Study
Mar 10, 2025, 14:00 PM -
Economic Impact of Patterned Frequency-Modulated Oral Stimulation in Preterm Infants
Mar 10, 2025, 14:00 PM -
Conceptual Mapping of Health-Related Quality of Life, Quality of Life, and Wellbeing: A Systematic Review and Assessment of Commonly Used Patient Reported Outcomes Measures
Mar 10, 2025, 14:00 PM -
Modeling the Potential Health Benefits of Improving Nutrition in Australian Indigenous Populations
Mar 10, 2025, 14:00 PM -
Investigating the Potential of Extracting Answers to Health-Related Quality of Life Questionnaires From Patient Community Data
Mar 10, 2025, 14:00 PM -
The Real-World Cost-Effectiveness of Faricimab Versus Existing and Future Biosimilars in Patients with Neovascular Age-Related Macular Degeneration in Canada
Mar 10, 2025, 14:00 PM -
Estimating the Potential Cost-Effectiveness of Long-Acting Naltrexone versus Oral Naltrexone for Alcohol Use Disorder
Mar 10, 2025, 14:00 PM -
Cost-Effectiveness Analysis of Olaparib and Niraparib With Abiraterone Versus Abiraterone for First-Line Treatment of BRCA Mutated Metastatic Castration-Resistant Prostate Cancer in Taiwan
Mar 10, 2025, 14:00 PM -
Is Bayesian Statistics an Emerging Way for Extrapolating Survival in Cost-Effectiveness Analysis: A Systematic Review
Mar 10, 2025, 14:00 PM -
Staffing Resource Use: A Cost Impact Model for the Utilization and Implementation of Medications for Opioid Use Disorder Within US Jails And Prisons
Mar 10, 2025, 14:00 PM -
Impact of Emicizumab on Quality of Life and Clinical Outcomes in Patients with Hemophilia A in Guatemala
Mar 10, 2025, 14:00 PM -
A Retrospective Real-World Data Analysis of Pregnancy Outcomes Among Women with a History of Hysteroscopic Intrauterine Adhesiolysis (HA), Other Intrauterine Surgery (IUs), or no Prior IUs
Mar 10, 2025, 14:00 PM -
Optimizing Adherence to Intravenous Iron: A Geographic Analysis of Variability Within the United States
Mar 10, 2025, 14:00 PM -
AMCP Dossier v5.0: U.S. Payer Preferences and Utilization to Support Formulary Decision Making
Mar 10, 2025, 14:00 PM
